Adjuvant capecitabine in triple negative breast cancer patients with residual disease after neoadjuvant treatment: real-world evidence from CaRe, a multicentric, observational study

Francesca Sofia Di Lisa, Enzo Veltri, Laura Pizzuti et al.|Frontiers in Oncology|2023

Cited by 9